MLM
CRDF icon

Mount Lucas Management’s Cardiff Oncology CRDF Stock Holding History

Mount Lucas Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-83
Closed -$32K – 132
2015
Q4 		$32K Buy
+83
New +$32.5K ﹤0.01% 102

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mount Lucas Management's CRDF Position: Q1 2016 in Review

Mount Lucas Management sold out of Cardiff Oncology (CRDF) in Q1 2016, closing a stake of 83 shares — an estimated $32K sold.

Mount Lucas Management first reported a position in CRDF in Q4 2015 and held it in 1 quarter. The position peaked at $32K in Q4 2015. 58 funds tracked by Wall St. Rank hold CRDF as of Q1 2016.

  • Mount Lucas Management reported no remaining Cardiff Oncology position as of Q1 2016 after selling out during the quarter.
  • Mount Lucas Management sold 83 Cardiff Oncology shares in Q1 2016, an estimated $32K.
  • Mount Lucas Management first reported a position in Cardiff Oncology in Q4 2015 and held it in 1 quarter.
  • Mount Lucas Management's Cardiff Oncology position peaked at $32K in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2016.

Based on Mount Lucas Management's 13F filing for Q1 2016, filed 16 May 2016.